| 3/27/2025 | BK | Market Commentary: Novolex, Fairbanks, Interstate Waste break; Paradigm updated; Opella, Grain accelerated
|
| 3/27/2025 | BK | Novolex shifts funds between term loans, firms at SOFR plus 325 bps
|
| 3/25/2025 | BK | Market Commentary: Bausch Health, M6 Midstream break; CohnReznick, Vista Global modified; Novolex accelerated
|
| 3/17/2025 | BK | Market Commentary: BRG breaks; Valvoline, Tacala accelerated; Novolex, M6, EnergySolutions, Red Oak set talk
|
| 3/17/2025 | BK | Novolex launches $2.91 billion of term loans at SOFR plus 325-350 bps
|
| 1/12/2017 | BKCVDDEMIGPV | Market Commentary: Icahn, Team Health, Zayo, MEG Energy lead $4.3 billion session; new issues jump
|
| 1/11/2017 | BKCVDDEMIGPV | Market Commentary: Novalex prices; Team Health ahead; Valeant down; other pharma companies follow; E&P mixed
|
| 1/10/2017 | BKCVDDEMIGPV | Market Commentary: Novolex on tap, Icahn on the road; Sabine Pass up on ratings boost, Valeant on asset sale
|
| 1/6/2017 | BKCVDDEMIGPV | Market Commentary: Quiet primary closes out year’s first week, new Lennar notes busy; Ruby Tuesday retreats
|
| 1/3/2017 | BKCVDDEMIGPV | Market Commentary: Primary opens year softly, as calendar expected to build; energy names busy as oil gyrates
|
| 12/9/2016 | BKDDHY | S&P rates Flex B, facilities B, notes CCC+
|
| 4/6/2016 | BK | S&P affirms Novolex on acquisition news
|
| 4/5/2016 | BK | Moody’s: Novolex view to stable
|
| 11/17/2014 | BK | S&P rates Novolex loans B, CCC+
|
